2020 Speakers

 

 

Bernadette Abela-Ridder, Team leader, Neglected Zoonotic Diseases, World Health Organization, United States

Bernadette Abela-Ridder | Team leader, Neglected Zoonotic Diseases | World Health Organization » speaking at Vaccine Europe

Mohammed Alquwaizani, Executive Director of Drug Risk Assessment, SFDA, Saudi Arabia

Mohammed Alquwaizani | Executive Director of Drug Risk Assessment | SFDA » speaking at Vaccine Europe

Dr Jean-Christophe Audonnet, Senior Director, International R&D Governance, Coordinator Of Zapi Imi Project, Merial, France

Dr Jean-Christophe Audonnet | Senior Director, International R&D Governance, Coordinator Of Zapi Imi Project | Merial » speaking at Vaccine Europe

Sandra Blome, Senior Scientist, Friedrich-Loeffler-Institut, Germany

Prof Marc Bonten, Professor, UMC Utrecht, Netherlands

Dr Miles Carroll, Dd, Public Health England, United Kingdom

Dr Danilo Casimiro, Vice President And Head, External Randd And Vaccine Platforms, Sanofi Pasteur, United States

Ajoy Chakrabarti, Portfolio And Platform Lead, The Bill & Melinda Gates Foundation, United States

Dr Ralf Clemens, Senior Vice President, Grid Rio, Germany

Dr Ralf Clemens | Senior Vice President | Grid Rio » speaking at Vaccine Europe

Richard Ducatelle, Head of the Laboratory of Veterinary Pathology, Gent University, Belgium

Richard Ducatelle | Head of the Laboratory of Veterinary Pathology | Gent University » speaking at Vaccine Europe

Cynthia Dukes, VP, Drug Development Services and Global Head of Vaccine Center of Excellence, ICON Clinical Research, United States

Elisabeth Erlacher Vindel, Head of the Antimicrobial Resistance and Veterinary Products Department, World Organisation for Animal Health, France

Elisabeth Erlacher Vindel | Head of the Antimicrobial Resistance and Veterinary Products Department | World Organisation for Animal Health » speaking at Vaccine Europe

Bin Feng, Senior Director, Head Of Advanced Analytics And Experimental Medicine Unit, GSK, United States

Bin Feng | Senior Director, Head Of Advanced Analytics And Experimental Medicine Unit | GSK » speaking at Vaccine Europe

Caitriona Fenton, One Health Operations Senior Manager, Zoetis, Ireland

Caitriona Fenton | One Health Operations Senior Manager | Zoetis » speaking at Vaccine Europe

Agnete Fredriksen, President And Chief Scientific Officer, Vaccibody AS, Norway

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK, United States

Gustav Gaudernack, Chief Scientific Officer, Ultimovacs, Norway

Gustav Gaudernack | Chief Scientific Officer | Ultimovacs » speaking at Vaccine Europe

Cyril Gay, Senior National Program Leader, A.R.S. National Programs, United States

Sarah Gilbert, Professor Of Vaccinology, University of Oxford, United Kingdom

Dr Beth Ann Griswold-Coller, Executive Director, Vaccines Clinical Research,, Merck Research Laboratories, United States

Professor Carlos Guzman, Head Of The Department Of Vaccinology And Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Germany

Dr Bart Haagmans, Working Group Leader, Department of Viroscience and Co-coordinator at ZAPI, Erasmus M.C., Netherlands

Dr Bassam Hallis, Head Of Pre Clinical Development And General Project Manager, Public Health England, United Kingdom

Dr Bassam Hallis | Head Of Pre Clinical Development And General Project Manager | Public Health England » speaking at Vaccine Europe

Ahd Hamidi, Project Director, Batavia Biosciences, Netherlands

Dr Jenny Hendriks, Head Biomarkers, Janssen Vaccines & Prevention B.V., Netherlands

Zahra Jawad, Group Leader Discovery Technology, Agenus, United Kingdom

Dr Karin Jooss, CSO, Gritstone Oncology, United States

Professor Gregers Jungersen, Professor Of Veterinary Immunology And Vaccinology, Technical University of Denmark, Denmark

Theo Kanellos, Director Of Business Development and Alliances, Zoetis, France

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc., United States

Naif Khalaf Alharbi, Associate Research Scientist, Infectious Disease Research Department, Head, Quality Management Department; Head, Safety Office,, King Abdullah International Medical Research Cente, Saudi Arabia

Naif Khalaf Alharbi | Associate Research Scientist, Infectious Disease Research Department, Head, Quality Management Department; Head, Safety Office, | King Abdullah International Medical Research Cente » speaking at Vaccine Europe

Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals, United States

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience, Austria

Professor Jeroen Kortekaas, Senior Scientist Virology, Wageningen University, Netherlands

Dr Anthony Simon Lynch, Senior Scientific Director, Janssen R&D, Netherlands

Ariane Mccabe, Director, Global Health And Public Affairs, GlaxoSmithKline, Switzerland

Ariane Mccabe | Director, Global Health And Public Affairs | GlaxoSmithKline » speaking at Vaccine Europe

Imraan Munshi, Executive Director And Global Communications Lead For Vaccines, MSD, United States

Louis Nel, Executive Director, Global Alliance for Rabies Control, United States

Louis Nel | Executive Director | Global Alliance for Rabies Control » speaking at Vaccine Europe

Prof Ab Osterhaus, Director, Research Center For Emerging Infections And Zoonoses (Riz), University of Veterinary Medicine Hannover, Netherlands

Sari Pesonen, Head Of R&D, Co-Founder, Valo Therapeutics, Finland

Dr Nikolai Petrovsky, Chairman, Vaxine Pty., Australia

Amy Pisani, Executive Director, Vaccinate Your Family, United States

Dr Jan Poolman, Head Bacterial Vaccine Discovery And Early Development, Janssen, Netherlands

Fatema H Rafiqi, Research Programme Manager, Access to Medicine Foundation, Netherlands

Andriy Rozstalnyy, Animal Production And Health Officer, F.A.O, Italy

Andriy Rozstalnyy | Animal Production And Health Officer | F.A.O » speaking at Vaccine Europe

Dr Hanneke Schuitemaker, Vice President And Head Of Viral Vaccine Discovery And Translational Medicine, Janssen, Netherlands

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC, United States

Terrence Stull, SVP Research, Phoenix Childrens Hospital, United States

Terrence Stull | SVP Research | Phoenix Childrens Hospital » speaking at Vaccine Europe

Carolina Tafalla, Head Researcher, I.N.I.A., Spain

Carolina Tafalla | Head Researcher | I.N.I.A. » speaking at Vaccine Europe

Jeroen van Bergen, CSO, Immunetune BV, Netherlands

Jeroen van Bergen | CSO | Immunetune BV » speaking at Vaccine Europe

Dr Joris Vandeputte, President, IABS, Belgium

Thomas Verstraeten, Managing Director P95, P95, Belgium

George Warimwe, Associate Professor of Vaccinology, University of Oxford, United Kingdom

George Warimwe | Associate Professor of Vaccinology | University of Oxford » speaking at Vaccine Europe

Professor Mark Wilcox, Professor Of Medical Microbiology And Deputy-Chair, Aprhai, University of Leeds, United Kingdom

Todd Wolynn, Chief Executive Officer And President, Kids Plus Pediatrics, United States

Todd Wolynn | Chief Executive Officer And President | Kids Plus Pediatrics » speaking at Vaccine Europe